
Food and Drug Administration
Organization
The Food and Drug Administration (FDA) is a federal agency of the United States Department of Health and Human Services responsible for protecting and promoting public health. It regulates food safety, tobacco products, dietary supplements, prescription and over-the-counter drugs, vaccines, and medical devices.
40 episodes featuring Food and Drug Administration

The Tim Ferriss Show
Kevin Ryan bets on durable trends over startup hype
Ryan’s record across technology, media, and healthcare offers a practical test for deciding which emerging markets can support enduring companies.
Sep 24, 2026 · 1h 26m

Something You Should Know
Optimism can be practiced, while cereal’s health halo gets unpacked
The episode connects deliberate emotional habits with a close look at how breakfast marketing shaped beliefs about nutrition and necessity.
Sep 24, 2026 · 53 min

unPAUSED with Dr. Mary Claire Haver
Why muscle may matter more than body fat for longevity
The conversation reframes aging health around muscle quality, metabolic function, and protein needs rather than weight alone.
Sep 22, 2026 · 56 min

The Sunday Roast
Sovereign AI and Namibia uranium lead a small-cap market review
The episode connects ambitious AI infrastructure plans and uranium exploration catalysts with governance, rates and valuation risks facing small-cap investors.
Sep 20, 2026 · 1h 35m

The Tim Ferriss Show
Australia’s psychedelic breakthrough offers advocates a regulatory playbook
The episode shows how coalition-building, clinical credibility, and persistent regulator engagement turned restricted psychedelic prescribing into Australian policy.
Sep 18, 2026 · 2h 12m

The Dylan Gemelli Podcast
Pet health advocate challenges conventional veterinary medicine
The conversation examines how diet, supplements, medications, and industry incentives may shape chronic illness and treatment choices for animals.
Sep 17, 2026 · 1h 11m

Raging Moderates with Scott Galloway and Jessica Tarlov
Tarlov makes the case for disagreement without alienation
The conversation connects democratic conflict abroad and political polarization at home to a practical question: how can people argue honestly without destroying relationships?
Sep 17, 2026 · 1h 22m

Something You Should Know
Art Markman explains why familiar minds misjudge everyday life
The episode shows how attention, familiarity, stress, and intentions quietly shape judgments, purchases, performance, and reactions to other people.
Sep 15, 2026 · 26 min

The Thyroid (and Hormone) Fixer Podcast: Thyropause, Menopause, Metabolism and How to Fix It
Iodine Supplements Raise Questions About Heavy Metals and Dose Control
Choosing an iodine supplement involves more than selecting a form, because contamination, inconsistent dosing, and thyroid monitoring can affect the decision.
Sep 15, 2026 · 35 min

Tomorrow, Today
Natalia Olson urges governments to innovate without abandoning public trust
The episode connects open data, experimentation and AI governance to a central question: how can public institutions modernize while protecting democracy and citizens?
Sep 15, 2026 · 1h 20m

Moonshots with Peter Diamandis
Martine Rothblatt links organ engineering to digital personhood
The conversation tests how regenerative medicine, xenotransplantation, and digital minds could reshape the boundaries of health, identity, and human life.
Sep 15, 2026 · 49 min

Raging Moderates with Scott Galloway and Jessica Tarlov
AI backlash collides with a volatile midterm landscape
The conversation links Democratic prospects, aging lawmakers, AI regulation, and historical election lessons to a broader struggle over political power and accountability.
Sep 14, 2026 · 51 min

The Joe Rogan Experience: Protect Our Parks
Andrew Huberman explains how neuroplasticity and discipline shape human behavior
This episode bridges the gap between hard neuroscience and daily practice, revealing how we can actively rewire our brains through physical strain, mental friction, and emerging technology.
Sep 14, 2026 · 2h 44m

The Sunday Roast
Small caps weigh longevity science against energy and mining risk
The episode connects geopolitical uncertainty and macroeconomic pressure with the scientific, regulatory and financing hurdles facing small-cap companies.
Sep 13, 2026 · 1h 38m

Fearless with Jason Whitlock
NFL abundance dulls regular-season urgency
The episode argues that longer schedules and more broadcast inventory are changing how teams, media, and audiences value individual games.
Sep 11, 2026 · 60 min

Modern Wisdom
Biohacking experts debate peptide regulations and hormone optimization strategies
As advanced therapies go mainstream, patients must navigate the tension between cutting-edge longevity science, regulatory crackdowns, and foundational lifestyle habits.
Sep 10, 2026 · 2h 51m

The Thyroid (and Hormone) Fixer Podcast: Thyropause, Menopause, Metabolism and How to Fix It
Pharmacist challenges prescription-first healthcare
The discussion asks whether medication decisions should begin with broader metabolic context, individualized thyroid testing, and lifestyle foundations rather than prescriptions alone.
Sep 8, 2026 · 54 min

Up First from NPR
Sunscreen science exposes gaps in testing and research
The episode shows why sunscreen can reduce some skin cancers while still falling short as a universal, fully tested solution across skin types.
Sep 6, 2026 · 29 min

The Dylan Gemelli Podcast
Dermatologist warns hidden melanomas evade visual checks
Early skin cancer can produce no symptoms and look ordinary, making thorough examinations and dermoscopy central to detection.
Sep 3, 2026 · 1h 3m

Something You Should Know
Food additives deserve evidence, not ingredient-list panic
The episode separates legitimate concerns about ultra-processed diets from the misleading idea that unfamiliar or artificial-sounding ingredients are inherently dangerous.
Sep 1, 2026 · 26 min

unPAUSED with Dr. Mary Claire Haver
Testosterone enters the menopause conversation
The episode examines what women’s testosterone may do, where evidence remains thin, and how dosing and monitoring shape treatment risk.
Sep 1, 2026 · 1h 13m

Moonshots with Peter Diamandis
Nvidia hits record revenue as global tech race reshapes security and space
The episode unpacks the massive economic and security implications of the AI boom, from hardware bubbles and surveillance networks to the geopolitical race for data center dominance.
Aug 29, 2026 · 2h 27m

Claude AI Daily
Anthropic, Apple and Stability AI reshape the tech agenda
The episode connects AI product changes, hardware strategy, industry financing and workforce forecasts in a fast-moving technology landscape.
Aug 26, 2026 · 17 min

The Vault Unlocked
Military antenna research takes an unexpected turn toward pain relief
The episode examines how a promising drug-free pain device balances striking personal stories with limited evidence and unresolved regulatory hurdles.
Aug 26, 2026 · 43 min

unPAUSED with Dr. Mary Claire Haver
Menopause care still lags behind women’s lived experience
The conversation connects perimenopause symptoms to brain, cardiovascular, sexual, and bone health while examining why informed treatment remains difficult to access.
Aug 25, 2026 · 1h 14m

unPAUSED with Dr. Mary Claire Haver
Women can build strength before menopause accelerates bone loss
The conversation treats frailty and osteoporosis as preventable risks, making screening, strength training, nutrition, and informed care central to longevity.
Aug 21, 2026 · 1h 21m

All-In with Chamath, Jason, Sacks & Friedberg
Tech leaders clash over open-source AI bans and DOJ antitrust investigations
The intersection of AI safety policy, venture capital antitrust scrutiny, and midterm economic anxiety will shape the future of American technological dominance and political alignment.
Aug 21, 2026 · 1h 31m

The Shawn Ryan Show
SEAL operator turns combat trauma into a mission of recovery
Alex West connects elite military service, combat loss, suicidal crisis, and sobriety to his later work helping veterans and first responders heal.
Aug 20, 2026 · 4h 35m

The Dylan Gemelli Podcast
Perlmutter links brain health to metabolism and immune defense
The conversation reframes cognitive decline as a long-term, measurable health challenge shaped by metabolism, lifestyle, immune activity, and purpose.
Aug 18, 2026 · 1h 16m

The Shawn Ryan Show
Koniver challenges medicine’s shortcuts with personalized longevity care
The conversation tests where individualized health optimization can offer useful alternatives—and where emerging therapies remain uncertain, experimental, or overpromoted.
Aug 13, 2026 · 2h 20m

Stock Movers
Rocket Lab climbs, Moderna wins approval, and Intel plans stock offering
Understanding these pivotal corporate developments reveals where major capital is flowing across the aerospace, biotechnology, and artificial intelligence sectors.
Aug 10, 2026 · 6 min

The Sunday Roast
Mining deals and biotech catalysts shape a midsummer market review
The episode tests how financing, clinical evidence, national resilience and exploration milestones could reshape several small-cap stories through 2026.
Aug 2, 2026 · 1h 45m

Stock Movers
Non-tech stocks surge and plunge as energy gains and biotech craters
Understanding market dynamics outside of tech is essential for identifying broader economic trends in energy, healthcare regulation, and global trade.
Jul 27, 2026 · 6 min

Stock Movers
European markets split as Galderma slumps and CMC Markets surges
Understanding these sharp market divergences reveals how regulatory decisions and retail health are reshaping the European corporate landscape.
Jul 1, 2026 · 7 min

The Herd with Colin Cowherd
Cormier questions Garry’s precise UFC 330 prediction
Garry’s confidence is central to the fight buildup, but Cormier argues that forecasting an exact finish could complicate how a victory is judged.
Jul 1, 2026 · 12 min

Stock Movers
AbbVie targets Apogee in eleven billion dollar deal as Regenxbio advances
Major pharmaceutical acquisitions and shifting regulatory pathways are rapidly redefining valuations in the biotechnology sector.
Jun 22, 2026 · 6 min

Stock Movers
SpaceX surges post-IPO as Netflix drops after losing Roku bid
This episode tracks the massive market disruptions caused by SpaceX's historic IPO, a major realignment in the streaming wars, and regulatory momentum for biotech.
Jun 16, 2026 · 6 min

The Sunday Roast
Biotech promise meets copper development risk
The episode contrasts Coiled Therapeutics’ clinical ambitions with Halo Minerals’ path from permitted project to copper production and expansion.
May 10, 2026 · 1h 9m

All-In with Chamath, Jason, Sacks & Friedberg
Elon Musk positions SpaceX as AI infrastructure powerhouse in Anthropic deal
The intersection of aerospace infrastructure, massive AI capital expenditure, and looming regulatory frameworks will decide which tech giants control the next era of computing.
May 8, 2026 · 1h 22m

Investor's Champion Podcast
UK small caps face a valuation test
The discussion weighs whether discounted UK equities offer genuine long-term value or reflect structural weaknesses, takeover risk and uneven growth prospects.
May 18, 2024 · 39 min
